MEGAN BENNETT: Open Payments
NPI 1235681123 · EASLEY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,584 in 100 payments from 25 companies in 2025. Trend: 2023 $1,495 · 2024 $1,569 · 2025 $1,584
Food & beverage: $1,575Education: $10
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $199 |
| ABBVIE INC. | 15 | $191 |
| AstraZeneca Pharmaceuticals LP | 8 | $191 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $160 |
| Lilly USA, LLC | 13 | $146 |
| HARMONY BIOSCIENCES LLC | 4 | $111 |
| PFIZER INC. | 5 | $89 |
| Otsuka America Pharmaceutical, Inc. | 4 | $87 |
| Esperion Therapeutics, Inc. | 4 | $68 |
| Vanda Pharmaceuticals Inc. | 3 | $50 |
Products named: Kerendia, UBRELVY, WAKIX, Ozempic, BREZTRI, REXULTI, FARXIGA, MOUNJARO.
Industry payments across SC — which companies pay providers there.
